Category: In the News
-

Critical Path Institute Launches New Approach Methodologies Developer Coalition to Advance Human-Relevant Tools for Drug Development
Global coalition unites NAMs developers to accelerate validation, qualification, and regulatory adoption of human-relevant methodologies, reducing reliance on animal models and improving the efficiency of drug development. TUCSON, Ariz., and AMSTERDAM, May 19, 2026 — Critical Path Institute® (C-Path) today announced the launch of the New Approach Methodologies Developer Coalition (NAMs-DC), a precompetitive, public-private initiative bringing…
-

Christopher Finch Named New Dean at the R. Ken Coit College of Pharmacy
Christopher K. Finch, PharmD, will join the University of Arizona on August 1 as the new dean of the R. Ken Coit College of Pharmacy. Finch currently serves as Chair and Professor at the University of Tennessee Health Science Center College of Pharmacy (UTHSC), which is ranked sixteenth nationally and twelfth in NIH research funding.…
-

ASU’s first human MRI enables breakthrough clinical studies
Researchers can now watch the brain in action Associate Professor Blair Braden (right) and members of ASU’s Autism and Brain Aging Lab examine brain specimens used in neuroscience research. Photo courtesy of the Autism and Brain Aging Lab Arizona State University researchers now have access to the university’s first MRI system approved for human scanning,…
-

Emmeline Ventures: Investing in Women’s Health, Innovation, and the Future of Venture Capital
Emmeline Ventures’s vision is simple: When more women are funded, our future becomes one of growth; opportunities no longer sit behind invisible doors. That philosophy was at the center of Emmeline Ventures’ conversation during Arizona Tech Week, where they offered a candid look at how they are reshaping venture capital through a focused lens on…
-

Arizona Microcredit Initiative Awards $7,000 in Prizes at 2nd Annual Pitch Competition for Underserved Entrepreneurs
Greater Phoenix nonprofit hosts entrepreneurial competition at 850PBC following three-workshop training cohort TEMPE, Ariz. — May 15th— The Arizona Microcredit Initiative (AMI), a 501(c)(3) nonprofit organization affiliated with Arizona State University, hosted its second annual pitch competition on May 8th at 850 PBC in Downtown Phoenix, awarding $7,000 in total prizes to entrepreneurs from underserved…
-

TGen appoints Nhan L. Tran, Ph.D., to faculty as distinguished professor
His lab will focus on advancing immuno‑oncology and microbiome innovation and research on understanding and interrupting tumor–immune interactions The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the appointment of Nhan L. Tran, Ph.D., to its faculty as Distinguished Professor, Vice President of Cancer Discovery and Translation, Co-director of TGen’s Immunology and Microbiome Division,…
-

Convocation Marks Class of 2026’s Final Step Toward Their Careers in Medicine
Members of the Class of 2026 process through the streets of Downtown Phoenix to the Orpheum Theatre. Ceremony commemorated and celebrated the end of their medical school journey For the Class of 2026, Monday, May 11, symbolized more than just the beginning of another week in medical school. As they processed through the streets of…
-

Internationally recognized oncology drug development leader and melanoma expert joins HonorHealth Research Institute
Dr. Nageatte Ibrahim helped guide the clinical development of Keytruda, one of the most consequential immuno-oncology therapies SCOTTSDALE, Ariz. — May 12, 2026 — Nageatte Ibrahim, M.D., an internationally recognized oncology drug development leader and immuno-oncology expert, has been appointed as Research Director of Developmental Therapeutics and Immuno-Oncology for HonorHealth Research Institute. Starting May 18,…
-

Google selects U of A for quantum research group focused on life sciences
The University of Arizona has been selected as one of only five academic institutions to partner with Google on a groundbreaking new research initiative exploring the intersection of life sciences and Quantum AI. The program, known as REPLIQA, will advance research into how quantum effects may influence biological systems and human physiology, opening new possibilities…










